🚀 VC round data is live in beta, check it out!
Vidavo Valuation Multiples
Discover revenue and EBITDA valuation multiples for Vidavo and similar public comparables like Induct, VSee Health, Media Lab, Synthetic MR and more.
Vidavo Overview
About Vidavo
Vidavo SA develops mobile applications that help citizens on-the-move and medical professionals manage health and wellness. The company serves health and social care providers, policymakers, insurance companies, ICT firms seeking differentiation, patients, telecom operators, and other health-related stakeholders. Its solutions include vida24, vidatrack, and vidahome.
Founded
2005
HQ
Employees
16
Website
Sectors
Financials (FY)
EV
$10M
Vidavo Financials
Vidavo reported last fiscal year revenue of $1M and EBITDA of $9K.
In the same fiscal year, Vidavo generated $429K in gross profit, $9K in EBITDA, and had net loss of ($36K).
Vidavo P&L
In the most recent fiscal year, Vidavo reported revenue of $1M and EBITDA of $9K.
Vidavo expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $1M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $429K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 33% | XXX | XXX | XXX |
| EBITDA | — | XXX | $9K | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 1% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (2%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($36K) | XXX | XXX | XXX |
| Net Margin | — | XXX | (3%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Vidavo Stock Performance
Vidavo has current market cap of $10M, and enterprise value of $10M.
Market Cap Evolution
Vidavo's stock price is $9.19.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $10M | $10M | -0.2% | XXX | XXX | XXX | $-0.03 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialVidavo Valuation Multiples
Vidavo trades at 7.6x EV/Revenue multiple, and 1100.5x EV/EBITDA.
Vidavo Financial Valuation Multiples
As of April 28, 2026, Vidavo has market cap of $10M and EV of $10M.
Equity research analysts estimate Vidavo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Vidavo has a P/E ratio of (270.6x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $10M | XXX | $10M | XXX | XXX | XXX |
| EV (current) | $10M | XXX | $10M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 7.6x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 1100.5x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (438.3x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 22.6x | XXX | XXX | XXX |
| P/E | — | XXX | (270.6x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (297.8x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Vidavo Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Vidavo Margins & Growth Rates
Vidavo's revenue in the last fiscal year grew by 57%.
Vidavo's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Vidavo Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 57% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 1% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (96%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 9% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 23% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 35% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Vidavo Public Comps
See public comps and valuation multiples for other EHR & Practice Management and Health Data & Analytics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Vidavo | XXX | XXX | XXX | XXX | XXX | XXX |
| Induct | XXX | XXX | XXX | XXX | XXX | XXX |
| VSee Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Media Lab | XXX | XXX | XXX | XXX | XXX | XXX |
| Synthetic MR | XXX | XXX | XXX | XXX | XXX | XXX |
| AMA Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Vidavo M&A Activity
Vidavo acquired XXX companies to date.
Last acquisition by Vidavo was on XXXXXXXX, XXXXX. Vidavo acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Vidavo
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialVidavo Investment Activity
Vidavo invested in XXX companies to date.
Vidavo made its latest investment on XXXXXXXX, XXXXX. Vidavo invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Vidavo
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Vidavo
| When was Vidavo founded? | Vidavo was founded in 2005. |
| Where is Vidavo headquartered? | Vidavo is headquartered in Greece. |
| How many employees does Vidavo have? | As of today, Vidavo has over 16 employees. |
| Is Vidavo publicly listed? | Yes, Vidavo is a public company listed on Athens Stock Exchange. |
| What is the stock symbol of Vidavo? | Vidavo trades under VIDAVO ticker. |
| When did Vidavo go public? | Vidavo went public in 2010. |
| Who are competitors of Vidavo? | Vidavo main competitors are Induct, VSee Health, Media Lab, Synthetic MR. |
| What is the current market cap of Vidavo? | Vidavo's current market cap is $10M. |
| What is the current revenue of Vidavo? | Vidavo's last fiscal year revenue is $1M. |
| What is the current EV/Revenue multiple of Vidavo? | Current revenue multiple of Vidavo is 7.6x. |
| Is Vidavo profitable? | No, Vidavo is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.